Logo

GnRH Analogues in the Prevention of Ovarian Hyperstimulation Syndrome

Author(s):
Pilar AlamaPilar Alama1, Jose BellverJose Bellver2, Carmen VidalCarmen Vidal1, Juan GilesJuan Giles1,*
1Department of Reproduction, IVI-Valencia, Plaza de la Policia Local, Valencia, Spain
2Department of Paediatrics, Obstetrics and Gynaecology, Faculty of Medicine. University of Valencia, Valencia, Spain


International Journal of Endocrinology and Metabolism:Vol. 11, issue 2; 107-16
Published online:Mar 31, 2013
Article type:Review Article
Received:Jul 08, 2012
Accepted:Aug 17, 2012
How to Cite:Pilar AlamaJose BellverCarmen VidalJuan GilesGnRH Analogues in the Prevention of Ovarian Hyperstimulation Syndrome.Int J Endocrinol Metab.11(2):107-16.https://doi.org/10.5812/ijem.5034.

Abstract

Abstract:

The GnRH analogue (agonist and antagonist GnRH) changed ovarian stimulation. On the one hand, it improved chances of pregnancy to obtain more oocytes and better embryos. This leads to an ovarian hyper-response, which can be complicated by the ovarian hyperstimulation syndrome (OHSS). On the other hand, the GnRH analogue can prevent the incidence of OHSS: GnRH antagonist protocols, GnRH agonist for triggering final oocyte maturation, either together or separately, coasting, and the GnRH analogue may prove useful for avoiding OHSS in high-risk patients. We review these topics in this article.

Full Text

Full text is available in PDF

comments

Leave a comment here


Crossmark
Crossmark
Checking
Share on
Metrics

Purchasing Reprints

  • Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here (   https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations

Author(s):

Related Articles